A multi-gene colorectal cancer liquid biopsy with >90% accuracy in diagnosis and assessment of disease status.
Modlin I, Kidd M, Kitz A, Drozdov I, Malczewska A, Kusnierz K, Aslanian H. A multi-gene colorectal cancer liquid biopsy with >90% accuracy in diagnosis and assessment of disease status. Journal Of Clinical Oncology 2020, 38: e16079-e16079. DOI: 10.1200/jco.2020.38.15_suppl.e16079.Peer-Reviewed Original ResearchStable diseaseColorectal cancerProgressive diseaseCA 19Cancer liquid biopsyLiquid biopsySurgical resection samplesBlood-based biomarkersCell linesResection samplesSurgical cohortSurgical resectionChemotherapy patientsCRC tumorsScore utilityClinical utilityBlood samplesColon cancerAUROC analysisDisease statusTumor tissueDiagnostic accuracyGene expressionCohortFunctional enrichment analysisSu1484 VALIDATION OF BASELINE CHARLSON COMORBIDITY INDEX (CACI) IN PREDICTING SURVIVAL IN A PANCREAS CYST SURVEILLANCE COHORT: AN INTERIM ANALYSIS
Chhoda A, Madhani K, Yousaf M, Aslanian H, Jamidar P, Muniraj T, Suarez A, Salem R, Farrell J. Su1484 VALIDATION OF BASELINE CHARLSON COMORBIDITY INDEX (CACI) IN PREDICTING SURVIVAL IN A PANCREAS CYST SURVEILLANCE COHORT: AN INTERIM ANALYSIS. Gastroenterology 2020, 158: s-598. DOI: 10.1016/s0016-5085(20)32198-3.Peer-Reviewed Original Research